ArticleMolecular cancer therapeutics2016

Posaconazole, a Second-Generation Triazole Antifungal Drug, Inhibits the Hedgehog Signaling Pathway and Progression of Basal Cell Carcinoma.

Baozhi Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.